We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AGC

News List

AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals en-cphi.cn
March 07, 2019
AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC).
AGC completes acquisition of Malgrat Pharma Chemicals biospectrumasia
March 04, 2019
The acquisition of MPC has allowed the AGC Group to obtain another manufacturing and sales base outside of Japan, following the acquisitions of two biopharmaceutical CDMO companies, Biomeva (2016) and CMC Biologics (2017)
AGC to Acquire Malgrat Pharma Chemicals americanpharmaceuticalreview
January 16, 2019
AGC has entered into an agreement with Boehringer Ingelheim to acquire its subsidiary Malgrat Pharma Chemicals, S.L.U. (MPC). Located in Spain, MPC manufactures synthetic pharmaceutical active ingredients used for ....

Previous page 1 2 Next page